JSPR

Jasper Therapeutics Inc

• Benzinga·04/02 21:05

  12 Health Care Stocks Moving In Thursday's After-Market Session

• TipRanks·04/02 12:40

  Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR), Alto Neuroscience, Inc. (ANRO) and Viridian Therapeutics (VRDN)

• Dow Jones·04/01 17:16

  Jasper Therapeutics Price Target Cut to $7.00/Share From $12.00 by Evercore ISI Group

• Dow Jones·04/01 17:16

  Jasper Therapeutics Is Maintained at Outperform by Evercore ISI Group

• Benzinga·04/01 17:06

  Evercore ISI Group Maintains Outperform on Jasper Therapeutics, Lowers Price Target to $7

• TipRanks·04/01 11:59

  Jasper Therapeutics price target lowered to $7 from $12 at Evercore ISI

• TipRanks·04/01 06:04

  Jasper Therapeutics’ Deep Cuts May Backfire: Analyst Warns Downsizing Could Undermine Briquilimab Strategy and Cash Runway

• TipRanks·03/31 16:30

  Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR), Pasithea Therapeutics Corp (KTTA) and RenovoRx (RNXT)

• TipRanks·03/31 11:11

  Analysts Are Neutral on Top Healthcare Stocks: Gilead Sciences (GILD), United Therapeutics (UTHR)

• TipRanks·03/31 10:26

  Buy Rating on Jasper: Briquilimab’s Strong CSU Efficacy, Favorable Safety, and Competitive Profile Underpin Key Near‑Term Value Driver

• Benzinga·03/30 21:05

  12 Health Care Stocks Moving In Monday's After-Market Session

• Dow Jones·03/30 20:33

  *Jasper Therapeutics 4Q Loss $9.1M >JSPR

• Reuters·03/30 20:32

  JASPER THERAPEUTICS Q4 EPS USD -0.32

• Dow Jones·03/30 20:30

  Press Release: Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

• Dow Jones·03/30 20:30

  *Jasper Therapeutics 4Q Loss/Shr 32c >JSPR